GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Construction In Progress

Voluntis (XPAR:ALVTX) Construction In Progress : €0.00 Mil (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Construction In Progress?

Voluntis's quarterly construction in progress declined from Jun. 2020 (€3.38 Mil) to Dec. 2020 (€0.00 Mil) but then stayed the same from Dec. 2020 (€0.00 Mil) to Jun. 2021 (€0.00 Mil).

Voluntis's annual construction in progress increased from Dec. 2018 (€0.00 Mil) to Dec. 2019 (€3.38 Mil) but then declined from Dec. 2019 (€3.38 Mil) to Dec. 2020 (€0.00 Mil).


Voluntis Construction In Progress Historical Data

The historical data trend for Voluntis's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Construction In Progress Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Construction In Progress
- - - 3.38 -

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.37 3.38 3.38 - -

Voluntis Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines